期刊文献+

Staging systems for hepatocellular carcinoma: Current status and future perspectives 被引量:10

Staging systems for hepatocellular carcinoma: Current status and future perspectives
下载PDF
导出
摘要 Hepatocellular carcinoma(HCC) is a major health concern worldwide and the third cause of cancer-related death. Despite advances in treatment as well as careful surveillance programs, the mortality rates in most countries are very high. In contrast to other cancers, the prognosis and treatment of HCC depend on the tumor burden in addition to patient's underlying liver disease and liver functional reserve. Moreover, thereis considerable geographic and institutional variation in both risk factors attributable to the underlying liver diseases and the management of HCC. Therefore, although many staging and/or scoring systems have been proposed, there is currently no globally accepted system for HCC due to the extreme heterogeneity of the disease. The aim of this review is to focus on currently available staging systems as well as those newly reported in the literatures since 2012. Moreover, we describe problems with currently available staging systems and attempts to modify and/or add variables to existing staging systems. Hepatocellular carcinoma (HCC) is a major healthconcern worldwide and the third cause of cancer-relateddeath. Despite advances in treatment as well as carefulsurveillance programs, the mortality rates in mostcountries are very high. In contrast to other cancers,the prognosis and treatment of HCC depend on thetumor burden in addition to patient's underlying liverdisease and liver functional reserve. Moreover, thereis considerable geographic and institutional variationin both risk factors attributable to the underlying liverdiseases and the management of HCC. Therefore,although many staging and/or scoring systems havebeen proposed, there is currently no globally acceptedsystem for HCC due to the extreme heterogeneityof the disease. The aim of this review is to focus oncurrently available staging systems as well as thosenewly reported in the literatures since 2012. Moreover,we describe problems with currently available stagingsystems and attempts to modify and/or add variables toexisting staging systems.
出处 《World Journal of Hepatology》 CAS 2015年第3期406-424,共19页 世界肝病学杂志(英文版)(电子版)
关键词 HEPATOCELLULAR CARCINOMA STAGING SYSTEM SCORING SYSTEM Prognosis Hepatocellular carcinoma Staging system Scoring system Prognosis
  • 相关文献

参考文献108

  • 1Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma.Lancet 2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/S0140-6736(11)61347-0].
  • 2Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma:clinical frontiers and perspectives. Gut 2014; 63: 844-855 [PMID:24531850 DOI: 10.1136/gutjnl-2013-306627].
  • 3European Association For The Study Of The Liver, EuropeanOrganisation For Research And Treatment Of Cancer. EASLEORTCclinical practice guidelines: management of hepatocellularcarcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438 DOI:10.1016/j.jhep.2011.12.001].
  • 4Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosisand staging for hepatocellular carcinoma. Oncologist 2010; 15Suppl 4: 23-33 [PMID: 21115578 DOI: 10.1634/theoncologist.2010-S4-23].
  • 5Olthoff KM, Forner A, Hübscher S, Fung J. What is the beststaging system for hepatocellular carcinoma in the setting of livertransplantation- Liver Transpl 2011; 17 Suppl 2: S26-S33 [PMID:21656653 DOI: 10.1002/lt.22352].
  • 6Maida M, Orlando E, Cammà C, Cabibbo G. Staging systemsof hepatocellular carcinoma: a review of literature. World JGastroenterol 2014; 20: 4141-4150 [PMID: 24764652 DOI:10.3748/wjg.v20.i15.4141].
  • 7Subramaniam S, Kelley RK, Venook Ap. A review of hepatocellularcarcinoma (HCC) staging systems. Chin Clin Oncol 2013; 2: 33Available from: URL: http: //www.thecco.net/article/view/2528.
  • 8Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K.Prognosis of primary hepatocellular carcinoma. Hepatology 1984; 4:3S-6S [PMID: 6319264].
  • 9Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N,Hasegawa H, Nakajima Y, Ohnishi K. Natural history ofhepatocellular carcinoma and prognosis in relation to treatment.Study of 850 patients. Cancer 1985; 56: 918-928 [PMID: 2990661].
  • 10A new prognostic system for hepatocellular carcinoma: aretrospective study of 435 patients: the Cancer of the Liver ItalianProgram (CLIP) investigators. Hepatology 1998; 28: 751-755[PMID: 9731568].

同被引文献33

引证文献10

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部